Speaker Information

Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), NIH

Wilson Compton, MD, MPE, Deputy Director, NIDA; Director (Acting) Office of Research Training, Diversity and Disparities (ORTDD), NIDA

Yasmin Hurd, PhD, Director, Addiction Institute at Mount Sinai, Icahn School of Medicine

Albert Avila, PhD, Deputy Director, ORTDD; Director, Office of Diversity and Health Disparities (ODHD), NIDA

Katrina Foster, PhD, Health Science Administrator, Clinical Research Grants Branch (CRGB), DTMC, NIDA

Holly Moore, PhD, Program Officer, Behavioral and Cognitive Neuroscience Branch (BCN), Division of Neuroscience and Behavior (DNB), NIDA

Keisher Highsmith, DrPH, Health Scientist Administrator, Services Research Branch (SRB), Division of Epidemiology, Services and Prevention Research (DESPR), NIDA

Dharmendar Rathore, PhD, Chief, Scientific Review Branch (SRB), Division of Extramural Research (DER), NIDA

Ivan Navarro, PhD, Scientific Review Officer, SRB, DER, NIDA

Guifang Lao, MD, PhD, Health Scientist Administrator/Training, Clinical/Medical Branch (CMB), DTMC, NIDA

Ann Anderson, MD, MPH, Medical Officer, CRGB, DTMC, NIDA

Aria Crump, ScD, Deputy Chief, Prevention Research Branch (PRB), DESPR, NIDA

Sarah Duffy, PhD, Associate Director for Economics Research, Deputy Chief, SRB, Division of Epidemiology, DESPR, NIDA

Roger Sorensen, PhD, MPA, Chief, Integrative Neuroscience Branch (INB), Division of Neuroscience and Behavior (DNB), NIDA

Yu (Woody) Lin, MD, PhD, Program Official, INB, DNB, NIDA